Vitamin D and SARS-Co V-2 virus/COVID-19 disease

Lanham-New, Sue, Webb, Anne R., Cashman, Kevin D., Buttriss, Judy, Fallowfield, Joanne, Masud, Tash, Hewison, Martin, Mathers, John, Kiely, Mairead, Welch, Ailsa, Ward, Kate, Magee, Pamela, Darling, Andrea, Hill, Tom, Grieg, Carolyn, Smith, Colin, Leyland, Sarah, Bouillon, Roger, Ray, Sumantra and Kohlmeier, Martin (2020) Vitamin D and SARS-Co V-2 virus/COVID-19 disease. BMJ Nutrition, Prevention and Health, 3 (1). ISSN 2516-5542

Preview

PDF (Published_Version) - Published Version Available under License Creative Commons Attribution Non-commercial. Download (298kB) | Preview

Abstract

Summary for social mediaVitamin D is essential for good health, especially bone and muscle health. Many people have low blood levels of vitamin D, especially in winter or if confined indoors, because summer sunshine is the main source of vitamin D for most people. Government vitamin D intake recommendations for the general population are 400 IU (10 µg) per day for the UK7 and 600 IU (15 µg) per day for the USA (800 IU (20 µg) per day for >70 years) and the EU.9 Taking a daily supplement (400 IU /day (10 µg/day) in the UK) and eating foods that provide vitamin D is particularly important for those self-isolating with limited exposure to sunlight. Vitamin D intakes greater than the upper limit of 4000 IU (100 µg) per day may be harmful and should be avoided unless under personal medical/clinical advice by a qualified health professional.

Item Type:	Article
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User:	LivePure Connector
Date Deposited:	03 Jun 2020 00:13
Last Modified:	24 May 2023 04:07
URI:	https://ueaeprints.uea.ac.uk/id/eprint/75442
DOI:	10.1136/bmjnph-2020-000089

Actions (login required)

View Item